Occurrence of oxa-48 carbapenemase and other β-lactamase genes in esbl-producing multidrug resistant: Escherichia coli from dogs and cats in the united states, 2009-2013

Frontiers in Microbiology

Volumn 7, Issue JUL, 2016, Pages

  Liu, Xiaoqiang ^a   Thungrat, Kamoltip ^a   Boothe, Dawn M ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b AUBURN UNIVERSITY   (United States)

Author keywords

Companion animals; ESBL; Escherichia coli; Multidrug resistance; OXA 48 carbapenemase

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; CARBAPENEMASE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; MEROPENEM; QUINOLONE; TIMENTIN;

ANIMAL DISEASE; ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CONJUGATION; BACTERIUM ISOLATION; CAT; CONTROLLED STUDY; DOG; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENE IDENTIFICATION; GENE TRANSFER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; UNITED STATES;

EID: 84982306134     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2016.01057     Document Type: Article

References (33)

1. Aly, S. A., Debavalya, N., Suh, S. J., Oryazabal, O. A., and Boothe, D. M. (2012). Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administration. Can. J. Microbiol. 58, 1288-1294. doi: 10.1139/w2012-105
2. Beutin, L. (1999). Escherichia coli as a pathogen in dogs and cats. Vet. Res. 30, 285-298.
3. Cantón, R., and Coque, T. M. (2006). The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466-475. doi: 10.1016/j.mib.2006.08.011
4. Clermont, O., Christenson, J. K., Denamur, E., and Gordon, D. M. (2013). The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 5, 58-65. doi: 10.1111/1758-2229.12019
5. CLSI (2013). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard. 4th Edn and Supplement, CLSI Document VET01-A4 (Standard) and VET01-S2 (Supplement). Wayne, PA: Clinical and Laboratory Standards Institute.
6. Cortés, P., Blanc, V., Mora, A., Dahbi, G., Blanco, J. E., Blanco, M., et al. (2010). Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl. Environ. Microbiol. 76, 2799-2805. doi: 10.1128/AEM.02421-09
7. Ewers, C., Bethe, A., Stamm, I., Grobbel, M., Kopp, P. A., Guerra, B., et al. (2014). CTX-M-15-D-ST648 Escherichia coli from companion animals and horses: another pandemic clone combining multiresistance and extraintestinal virulence? J. Antimicrob. Chemother. 69, 1224-1230. doi: 10.1093/jac/dkt516
8. Geser, N., Stephan, R., and Hächler, H. (2012). Occurrence and characteristics of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk. BMC Vet. Res. 8:21. doi: 10.1186/1746-6148-8-21
9. Girlich, D., Bouihat, N., Poirel, L., Benouda, A., and Nordmann, P. (2014). High rate of faecal carriage of extended-spectrum beta-lactamase and OXA-48 carbapenemase-producing Enterobacteriaceae at a university hospital in Morocco. Clin. Microbiol. Infect. 20, 350-354. doi: 10.1111/1469-0691.12325
10. Guet-Revillet, H., Emirian, A., Groh, M., Nebbad-Lechani, B., Weiss, E., Join-Lambert, O., et al. (2014). Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob. Agents Chemother. 58, 4899-4901. doi: 10.1128/AAC.02509-14
11. He, D., Partridge, S. R., Shen, J., Zeng, Z., Liu, L., Rao, L., et al. (2013). CTX-M-123, a novel hybrid of the CTX-M-1 and CTX-M-9 Group beta-lactamases recovered from Escherichia coli isolates in China. Antimicrob. Agents Chemother. 57, 4068-4071. doi: 10.1128/AAC.00541-13
12. Hu, Y. Y., Cai, J. C., Zhou, H. W., Chi, D., Zhang, X. F., Chen, W. L., et al. (2013). Molecular typing of CTX-M-producing Escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl. Environ. Microbiol. 79, 5988-5996. doi: 10.1128/AEM.01740-13
13. Huber, H., Zweifel, C., Wittenbrink, M. M., and Stephan, R. (2013). ESBL-producing uropathogenic Escherichia coli isolated from dogs and cats in Switzerland. Vet. Microbiol. 162, 992-996. doi: 10.1016/j.vetmic.2012.10.029
14. Johnson, J. R., and Stell, A. L. (2000). Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181, 261-272. doi: 10.1086/315217
15. Karisik, E., Ellington, M. J., Livermore, D. M., and Woodford, N. (2008). Virulence factors in Escherichia coli with CTX-M-15 and other extended-spectrum beta-lactamases in the UK. J. Antimicrob. Chemother. 61, 54-58. doi: 10.1093/jac/dkm401
16. Li, X. Z., Mehrotra, M., Ghimire, S., and Adewoye, L. (2007). beta-Lactam resistance and beta-lactamases in bacteria of animal origin. Vet. Microbiol. 121, 197-214. doi: 10.1016/j.vetmic.2007.01.015
17. Liu, X., Boothe, D. M., Thungrat, K., and Aly, S. (2012). Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals. Vet. Microbiol. 161, 159-168. doi: 10.1016/j.vetmic.2012.07.019
18. Liu, X., Thungrat, K., and Boothe, D. M. (2015). Multilocus sequence typing and virulence profiles in uropathogenic Escherichia coli isolated from cats in the United States. PLoS ONE 10:e0143335. doi: 10.1371/journal.pone.0143335
19. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., et al. (2012). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268-281. doi: 10.1111/j.1469-0691.2011.03570.x
20. Mathers, A. J., Hazen, K. C., Carroll, J., Yeh, A. J., Cox, H. L., Bonomo, R. A., et al. (2013). First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J. Clin. Microbiol. 51, 680-683. doi: 10.1128/JCM.02580-12
21. Nicolas-Chanoine, M. H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., et al. (2008). Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61, 273-281. doi: 10.1093/jac/dkm464
22. O'Keefe, A., Hutton, T. A., Schifferli, D. M., and Rankin, S. C. (2010). First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob. Agents Chemother. 54, 3489-3492. doi: 10.1128/AAC.01701-09
23. Pitout, J. D. (2012). Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front. Microbiol. 3:9. doi: 10.3389/fmicb.2012.00009
24. Poirel, L., Héritier, C., Tolun, V., and Nordmann, P. (2004). Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48, 15-22. doi: 10.1128/AAC.48.1.15-22.2004
25. Poirel, L., Potron, A., and Nordmann, P. (2012). OXA-48-like carbapenemases: the phantom menace. J. Antimicrob. Chemother. 67, 1597-1606. doi: 10.1093/jac/dks121
26. Poirel, L., Walsh, T. R., Cuvillier, V., and Nordmann, P. (2011). Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70, 119-123. doi: 10.1016/j.diagmicrobio.2010.12.002
27. Qin, X., Hu, F., Wu, S., Ye, X., Zhu, D., Zhang, Y., et al. (2013). Comparison of adhesin genes and antimicrobial susceptibilities between uropathogenic and intestinal commensal Escherichia coli strains. PLoS ONE 8:e61169. doi: 10.1371/journal.pone.0061169
28. Schmiedel, J., Falgenhauer, L., Domann, E., Bauerfeind, R., Prenger-Berninghoff, E., Imirzalioglu, C., et al. (2014). Multiresistant extended-spectrum beta-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany. BMC Microbiol. 14:187. doi: 10.1186/1471-2180-14-187
29. Shaheen, B. W., Nayak, R., Foley, S. L., Kweon, O., Deck, J., Park, M., et al. (2011). Molecular characterization of resistance to extended-spectrum cephalosporins in clinical Escherichia coli isolates from companion animals in the United States. Antimicrob. Agents Chemother. 55, 5666-5675. doi: 10.1128/AAC.00656-11
30. Sidjabat, H. E., Seah, K. Y., Coleman, L., Sartor, A., Derrington, P., Heney, C., et al. (2014). Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli. Int. J. Antimicrob. Agents 44, 203-208. doi: 10.1016/j.ijantimicag.2014.04.016
31. Stolle, I., Prenger-Berninghoff, E., Stamm, I., Scheufen, S., Hassdenteufel, E., Guenther, S., et al. (2013). Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J. Antimicrob. Chemother. 68, 2802-2808. doi: 10.1093/jac/dkt259
32. Thungrat, K., Price, S. B., Carpenter, D. M., and Boothe, D. M. (2015). Antimicrobial susceptibility patterns of clinical Escherichia coli isolates from dogs and cats in the United States: January 2008 through January 2013. Vet. Microbiol. 179, 287-295. doi: 10.1016/j.vetmic.2015.06.012
33. Yan, J. J., Hong, C. Y., Ko, W. C., Chen, Y. J., Tsai, S. H., Chuang, C. L., et al. (2004). Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob. Agents Chemother. 48, 1353-1356. doi: 10.1128/AAC.48.4.1353-1356.2004